Cargando…
Development and effectiveness of pseudotyped SARS-CoV-2 system as determined by neutralizing efficiency and entry inhibition test in vitro
With the development of the COVID-19 epidemic, there is an urgent need to establish a system for determining the effectiveness and neutralizing activity of vaccine candidates in biosafety level 2 (BSL-2) facilities. Previously, researchers had developed a pseudotyped virus system for SARS-CoV and ME...
Autores principales: | Yang, Ren, Huang, Baoying, A, Ruhan, Li, Wenhui, Wang, Wenling, Deng, Yao, Tan, Wenjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Medical Association Publishing House. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442068/ https://www.ncbi.nlm.nih.gov/pubmed/32864605 http://dx.doi.org/10.1016/j.bsheal.2020.08.004 |
Ejemplares similares
-
Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections
por: Yang, Ren, et al.
Publicado: (2020) -
The role of pseudotype neutralization assays in understanding SARS CoV-2
por: Cantoni, Diego, et al.
Publicado: (2021) -
Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol
por: Condor Capcha, Jose Manuel, et al.
Publicado: (2021) -
Summary of the Detection Kits for SARS-CoV-2 Approved by the National Medical Products Administration of China and Their Application for Diagnosis of COVID-19
por: A, Ruhan, et al.
Publicado: (2020) -
Novaferon Effectively Inhibits Ancestral SARS-CoV-2 and Omicron Variant in
Vitro, 2022
por: Ye, Fei, et al.
Publicado: (2022)